Repare Therapeutics Inc. Stock-Based Compensation
Repare Therapeutics Inc. reported Stock-Based Compensation of $7.46 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2025-11-14
- Repare Therapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.41M, a 73.15% decline year-over-year.
- Repare Therapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $2.07M, a 68.22% decline year-over-year.
- Repare Therapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $3.98M, a 38.61% decline year-over-year.
- Repare Therapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-12-31 was $4.93M, a 22.50% decline year-over-year.
- Repare Therapeutics Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $23.17M, a 7.55% decline from fiscal 2023.
- Repare Therapeutics Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $25.06M, a 27.28% increase from fiscal 2022.
- Repare Therapeutics Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $19.69M, a 53.49% increase from fiscal 2021.
- Repare Therapeutics Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $12.83M, a 405.68% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $3.48M derived: sum of 2 quarters · filed 2025-11-14 | $7.46M 10-Q · filed 2025-11-14 | $12.38M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $6.05M 10-Q · filed 2025-08-08 | $10.97M derived: sum of 3 quarters · filed 2025-08-08 | $16.22M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | $3.98M 10-Q · filed 2025-05-13 | $8.90M derived: sum of 2 quarters · filed 2025-05-13 | $14.15M derived: sum of 3 quarters · filed 2025-11-14 | $20.67M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | $4.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $10.18M derived: sum of 2 quarters · filed 2025-11-14 | $16.70M derived: sum of 3 quarters · filed 2025-11-14 | $23.17M 10-K · filed 2025-03-03 |
| 2024-09-30 | $5.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $11.77M derived: sum of 2 quarters · filed 2025-11-14 | $18.24M 10-Q · filed 2025-11-14 | $24.60M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $6.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $12.99M 10-Q · filed 2025-08-08 | $19.35M derived: sum of 3 quarters · filed 2025-08-08 | $25.73M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $6.47M 10-Q · filed 2025-05-13 | $12.83M derived: sum of 2 quarters · filed 2025-05-13 | $19.21M derived: sum of 3 quarters · filed 2025-05-13 | $25.48M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $6.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $12.74M derived: sum of 2 quarters · filed 2025-03-03 | $19.00M derived: sum of 3 quarters · filed 2025-03-03 | $25.06M 10-K · filed 2025-03-03 |
| 2023-09-30 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $12.64M derived: sum of 2 quarters · filed 2024-11-07 | $18.70M 10-Q · filed 2024-11-07 | $23.84M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $6.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $12.33M 10-Q · filed 2024-08-06 | $17.46M derived: sum of 3 quarters · filed 2024-08-06 | $22.52M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $6.06M 10-Q · filed 2024-05-07 | $11.20M derived: sum of 2 quarters · filed 2024-05-07 | $16.25M derived: sum of 3 quarters · filed 2024-05-07 | $21.00M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $5.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $10.19M derived: sum of 2 quarters · filed 2024-02-28 | $14.94M derived: sum of 3 quarters · filed 2024-02-28 | $19.69M 10-K · filed 2024-02-28 |
| 2022-09-30 | $5.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $9.80M derived: sum of 2 quarters · filed 2023-11-09 | $14.55M 10-Q · filed 2023-11-09 | $18.45M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $4.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $9.50M 10-Q · filed 2023-08-09 | $13.40M derived: sum of 3 quarters · filed 2023-08-09 | $17.09M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $4.75M 10-Q · filed 2023-05-09 | $8.65M derived: sum of 2 quarters · filed 2023-05-09 | $12.34M derived: sum of 3 quarters · filed 2023-05-09 | $15.53M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $7.59M derived: sum of 2 quarters · filed 2023-02-28 | $10.77M derived: sum of 3 quarters · filed 2023-02-28 | $12.83M 10-K · filed 2023-02-28 |
| 2021-09-30 | $3.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $6.88M derived: sum of 2 quarters · filed 2022-11-09 | $8.93M 10-Q · filed 2022-11-09 | $9.94M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $5.24M 10-Q · filed 2022-08-04 | $6.25M derived: sum of 3 quarters · filed 2022-08-04 | $7.12M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $2.06M 10-Q · filed 2022-05-05 | $3.06M derived: sum of 2 quarters · filed 2022-05-05 | $3.93M derived: sum of 3 quarters · filed 2022-05-05 | $4.32M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.88M derived: sum of 2 quarters · filed 2022-03-01 | $2.27M derived: sum of 3 quarters · filed 2022-03-01 | $2.54M 10-K · filed 2022-03-01 |
| 2020-09-30 | $871.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.26M derived: sum of 2 quarters · filed 2021-11-10 | $1.53M 10-Q · filed 2021-11-10 | $1.73M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $389.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $660.00K 10-Q · filed 2021-08-12 | $858.00K derived: sum of 3 quarters · filed 2022-03-01 | $985.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $271.00K 10-Q · filed 2021-05-13 | $469.00K derived: sum of 2 quarters · filed 2022-03-01 | $596.00K derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | $198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $325.00K derived: sum of 2 quarters · filed 2022-03-01 | $511.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $313.00K 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $186.00K 10-Q · filed 2020-08-13 |